Skip to content
HowShorted

RHYTHM PHARMACEUTICALS, INC. short interest in 2023

In 2023, RHYTHM PHARMACEUTICALS, INC.'s disclosed short interest ran from 14.07% of shares outstanding on 13 Jan 2023 to 13.77% on 29 Dec 2023, a change of -0.30 percentage points. The year's high was 21.81% on 31 Jul 2023 and its low 13.10% on 15 Mar 2023, averaging 16.79% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.55 days on 15 Jun 2023. Full history: RHYTHM PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for RHYTHM PHARMACEUTICALS, INC. in 2023

2023 in figures

Start of year
14.07% (13 Jan 2023)
End of year
13.77% (29 Dec 2023)
Change
-0.30 pp
High
21.81% (31 Jul 2023)
Low
13.10% (15 Mar 2023)
Average
16.79%
Highest days to cover
27.55 (15 Jun 2023)
SEC filings marked
8

Every report in 2023

RHYTHM PHARMACEUTICALS, INC. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202314.07%12.23
31 Jan 202313.73%13.09
15 Feb 202314.45%20.52
28 Feb 202314.40%17.38
15 Mar 202313.10%7.6410-K filed, results (8-K)
31 Mar 202314.26%11.27
14 Apr 202314.49%14.59
28 Apr 202314.87%15.64
15 May 202315.78%11.3910-Q filed, results (8-K)
31 May 202317.05%14.95
15 Jun 202317.47%27.55
30 Jun 202319.34%7.87
14 Jul 202320.20%18.64
31 Jul 202321.81%24.80
15 Aug 202319.26%8.9010-Q filed, results (8-K)
31 Aug 202318.72%17.15
15 Sep 202321.05%17.38
29 Sep 202317.73%19.40
13 Oct 202320.72%22.81
31 Oct 202320.48%27.30
15 Nov 202315.93%12.29results (8-K), 10-Q filed
30 Nov 202315.66%16.17
15 Dec 202314.62%9.02
29 Dec 202313.77%10.56

See also: RHYTHM PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.